資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Cell Counting Market by Product, End User - Global Forecast to 2020

  • LinkedIn
  • facebook
  • Twitter
出 版 商:MarketsandMarkets
出版日期:2015/05/07
頁  數:189頁
文件格式:PDF
價  格:
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
線上訂購或諮詢
Over the past five years, the cell counting market has witnessed tremendous growth primarily due to high prevalence of AIDS and cancer across the globe and increasing stem cell research expenditure.

In this report, the global cell counting market is segmented on the basis of products, end users, and by region. On the basis of products, the cell counting market is categorized into spectrophotometers, flow cytometers, hematology analyzers, and cell counters. The spectrophotometers segment is further divided into single-mode readers and multi-mode readers; whereas, the cell counters segment is categorized into automated cell counters; and hemocytometers and manual cell counters. On the basis of end users, the cell counting market is divided into hospitals and diagnostic laboratories, research institutions, pharmaceutical and biotechnology companies, and other end users. In addition, country-wise segmentation of each region is also provided in the report.

The global cell counting market is expected to grow at a significant CAGR of around 6.5% to 7% during the forecast period (2015 to 2020). The market is mainly driven by the growing stem cell research, introduction of enhanced data visualization and analysis software, and upsurge in government and corporate funding for R&D. However, lack of proper healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of advanced cell counting systems are hampering the growth of this market to a certain extent.

Spectrophotometers accounted for a major share of the cell counting market. The market for spectrophotometers is primarily driven by the introduction of enhanced data visualization and analysis software. In addition, increased automation in research laboratories and growth in the healthcare and biotechnology industry of the emerging countries are further driving the growth of the spectrophotometers market.

In 2014, North America accounted for the largest share to the global cell counting market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced cell counting instruments, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global cell counting market is dominated by six players that accounted for around 65% to 70% of the global market in 2014. Major players in this market are Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios offered by the top players in the cell counting market. The report analyzes the cell counting market by product and end user across all regions
‧ Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the cell counting market
‧ Market Development: Comprehensive information on the lucrative emerging markets by product, end user, and region
‧ Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the cell counting market
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the cell counting market
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY AND PRICING 18
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 MARKET SHARE ESTIMATION 25
2.4.1 KEY DATA FROM SECONDARY SOURCES 25
2.4.2 KEY DATA FROM PRIMARY SOURCES 26
2.4.3 KEY INDUSTRY INSIGHTS 27
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 GROWTH POTENTIAL OF THE GLOBAL CELL COUNTING MARKET 33
4.2 ASIA-PACIFIC: CELL COUNTING MARKET, BY PRODUCT (2015) 34
4.3 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL CELL COUNTING MARKET 35
4.4 NORTH AMERICA TO DOMINATE THE GLOBAL CELL COUNTING MARKET DURING THE FORECAST PERIOD 36
4.5 GLOBAL CELL COUNTING MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 39
5.2.1 BY TYPE 39
5.2.2 BY END USER 39
5.3 KEY MARKET DYNAMICS 40
5.3.1 MARKET DRIVERS 41
5.3.1.1 Rising incidence of cancer and high prevalence of AIDS 41
5.3.1.2 Corporate & government funding and investments for cell-based research 42
5.3.1.3 Development of enhanced informatics solutions and improved image analysis instruments 42
5.3.2 MARKET RESTRAINTS 43
5.3.2.1 High prices of advanced cell counting systems 43
5.3.2.2 Reluctance among researchers to use advanced cell counting techniques 44
5.3.3 MARKET OPPORTUNITIES 44
5.3.3.1 Fostering stem cell research 44
5.3.3.2 Emerging markets 45
5.3.4 MARKET CHALLENGES 46
5.3.4.1 Lack of proper healthcare and research infrastructure in emerging markets 46
5.3.4.2 Dearth of skilled professionals in clinical laboratories 46
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 VALUE CHAIN ANALYSIS 47
6.3 INDUSTRY TRENDS 49
6.3.1 INCREASING DEMAND FOR SMALL-SCALE AUTOMATED CELL COUNTING INSTRUMENTS 50
6.3.2 INTEGRATION OF BASIC FLOW CYTOMETRY TECHNIQUES IN MODERN HEMATOLOGY ANALYZERS 50
6.3.3 ACQUISITION OF SMALL PLAYERS 50
6.4 PORTER’S FIVE FORCES ANALYSIS 51
6.4.1 THREAT OF NEW ENTRANTS 51
6.4.2 THREAT OF SUBSTITUTES 51
6.4.3 BARGAINING POWER OF SUPPLIERS 52
6.4.4 BARGAINING POWER OF BUYERS 52
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 52
7 GLOBAL CELL COUNTING MARKET, BY PRODUCT 53
7.1 INTRODUCTION 54
7.2 CONSUMABLES AND ACCESSORIES 56
7.2.1 REAGENTS 57
7.2.2 ASSAY KITS 58
7.2.3 MICROPLATES 59
7.2.4 ACCESSORIES 60
7.2.5 OTHER CONSUMABLES 62
7.3 INSTRUMENTS 63
7.3.1 SPECTROPHOTOMETERS 64
7.3.1.1 Single-mode Readers 66
7.3.1.2 Multi-mode Readers 67
7.3.2 FLOW CYTOMETERS 68
7.3.3 HEMATOLOGY ANALYZERS 70
7.3.4 CELL COUNTERS 71
7.3.4.1 Automated Cell Counters 73
7.3.4.2 Hemocytometers and Manual Cell Counters 74
8 CELL COUNTING MARKET, BY END USER 75
8.1 INTRODUCTION 76
8.2 RESEARCH INSTITUTIONS 77
8.3 HOSPITALS AND DIAGNOSTIC LABORATORIES 78
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 80
8.5 OTHER END USERS 81
9 GLOBAL CELL COUNTING MARKET, BY REGION 84
9.1 INTRODUCTION 85
9.2 NORTH AMERICA 86
9.2.1 U.S. 90
9.2.2 CANADA 93
9.3 EUROPE 97
9.3.1 GERMANY 100
9.3.2 FRANCE 103
9.3.3 U.K. 106
9.3.4 ITALY 109
9.3.5 SPAIN 112
9.3.6 REST OF EUROPE 115
9.4 ASIA-PACIFIC 118
9.4.1 JAPAN 123
9.4.2 CHINA 126
9.4.3 INDIA 129
9.4.4 REST OF ASIA-PACIFIC 132
9.5 REST OF THE WORLD (ROW) 135
9.5.1 LATIN AMERICA 138
9.5.2 MIDDLE EAST AND AFRICA 141
10 COMPETITIVE LANDSCAPE 144
10.1 OVERVIEW 144
10.2 MARKET SHARE ANALYSIS 145
10.3 COMPETITIVE SITUATION AND TRENDS 146
10.4 NEW PRODUCT LAUNCHES 147
10.5 EXPANSIONS 148
10.6 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 149
10.7 MERGERS AND ACQUISITIONS 150

11 COMPANY PROFILES 151
11.1 INTRODUCTION 151
11.2 DANAHER CORPORATION 152
11.3 THERMO FISHER SCIENTIFIC, INC. 155
11.4 BECTON, DICKINSON, AND COMPANY 158
11.5 MERCK MILLIPORE 161
11.6 BIO-RAD LABORATORIES, INC. 164
11.7 GE HEALTHCARE 167
11.8 PERKINELMER, INC. 170
11.9 BIOTEK INSTRUMENTS, INC. 173
11.10 AGILENT TECHNOLOGIES, INC. 175
11.11 TECAN GROUP LTD. 178
12 APPENDIX 181
12.1 INSIGHTS OF INDUSTRY EXPERTS 181
12.2 DISCUSSION GUIDE 182
12.3 AVAILABLE CUSTOMIZATIONS 185
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 186
12.5 RELATED REPORTS 188
回上頁